These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 35195941)

  • 1. Multi-targeted Drug Repurposing Approach for Breast Cancer via Integrated Functional Network Analysis.
    Kandasamy T; Sen P; Ghosh SS
    Mol Inform; 2022 Aug; 41(8):e2100300. PubMed ID: 35195941
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting EMT in Cancer with Repurposed Metabolic Inhibitors.
    Ramesh V; Brabletz T; Ceppi P
    Trends Cancer; 2020 Nov; 6(11):942-950. PubMed ID: 32680650
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug Combinations: A New Strategy to Extend Drug Repurposing and Epithelial-Mesenchymal Transition in Breast and Colon Cancer Cells.
    Duarte D; Rêma A; Amorim I; Vale N
    Biomolecules; 2022 Jan; 12(2):. PubMed ID: 35204691
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In silico repurposing of antipsychotic drugs for Alzheimer's disease.
    Kumar S; Chowdhury S; Kumar S
    BMC Neurosci; 2017 Oct; 18(1):76. PubMed ID: 29078760
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel anthraquinone‑quinazoline hybrid 7B blocks breast cancer metastasis and EMT via targeting EGFR and Rac1.
    Kang J; Zhong Y; Tian W; Li J; Li X; Zhai L; Hou H; Li D
    Int J Oncol; 2021 May; 58(5):. PubMed ID: 33760108
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pimozide Suppresses the Growth of Brain Tumors by Targeting STAT3-Mediated Autophagy.
    Ranjan A; Kaushik I; Srivastava SK
    Cells; 2020 Sep; 9(9):. PubMed ID: 32971907
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Twist induces epithelial-mesenchymal transition and cell motility in breast cancer via ITGB1-FAK/ILK signaling axis and its associated downstream network.
    Yang J; Hou Y; Zhou M; Wen S; Zhou J; Xu L; Tang X; Du YE; Hu P; Liu M
    Int J Biochem Cell Biol; 2016 Feb; 71():62-71. PubMed ID: 26693891
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The mechanism of action of Fangji Huangqi Decoction on epithelial-mesenchymal transition in breast cancer using high-throughput next-generation sequencing and network pharmacology.
    Guo Q; Pei XH; Chu AJ; Guo YB; Fan YY; Wang CH; Zhang SJ; Sun SQ; Liu YF; Wang X
    J Ethnopharmacol; 2022 Feb; 284():114793. PubMed ID: 34728317
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel drug repurposing approach for non-small cell lung cancer using deep learning.
    Li B; Dai C; Wang L; Deng H; Li Y; Guan Z; Ni H
    PLoS One; 2020; 15(6):e0233112. PubMed ID: 32525938
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GSK3β regulates epithelial-mesenchymal transition and cancer stem cell properties in triple-negative breast cancer.
    Vijay GV; Zhao N; Den Hollander P; Toneff MJ; Joseph R; Pietila M; Taube JH; Sarkar TR; Ramirez-Pena E; Werden SJ; Shariati M; Gao R; Sobieski M; Stephan CC; Sphyris N; Miura N; Davies P; Chang JT; Soundararajan R; Rosen JM; Mani SA
    Breast Cancer Res; 2019 Mar; 21(1):37. PubMed ID: 30845991
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Virtual screening-driven repositioning of etoposide as CD44 antagonist in breast cancer cells.
    Aguirre-Alvarado C; Segura-Cabrera A; Velázquez-Quesada I; Hernández-Esquivel MA; García-Pérez CA; Guerrero-Rodríguez SL; Ruiz-Moreno AJ; Rodríguez-Moreno A; Pérez-Tapia SM; Velasco-Velázquez MA
    Oncotarget; 2016 Apr; 7(17):23772-84. PubMed ID: 27009862
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular property diagnostic suite for diabetes mellitus (MPDS
    Gaur AS; Nagamani S; Tanneeru K; Druzhilovskiy D; Rudik A; Poroikov V; Narahari Sastry G
    J Biomed Inform; 2018 Sep; 85():114-125. PubMed ID: 30092360
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phosphorylated STAT3 (Tyr705) as a biomarker of response to pimozide treatment in triple-negative breast cancer.
    Dees S; Pontiggia L; Jasmin JF; Mercier I
    Cancer Biol Ther; 2020 Jun; 21(6):506-521. PubMed ID: 32164483
    [TBL] [Abstract][Full Text] [Related]  

  • 14. miRNA‑490‑3p promotes the metastatic progression of invasive ductal carcinoma.
    Lu N; Zhang M; Lu L; Liu YZ; Zhang HH; Liu XD
    Oncol Rep; 2021 Feb; 45(2):706-716. PubMed ID: 33416185
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Integrin alpha-2 and beta-1 expression increases through multiple generations of the EDW01 patient-derived xenograft model of breast cancer-insight into their role in epithelial mesenchymal transition in vivo gained from an in vitro model system.
    Wafai R; Williams ED; de Souza E; Simpson PT; McCart Reed AE; Kutasovic JR; Waltham M; Snell CE; Blick T; Thompson EW; Hugo HJ
    Breast Cancer Res; 2020 Dec; 22(1):136. PubMed ID: 33276802
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular Docking and Dynamics Simulation Revealed Ivermectin as Potential Drug against
    Siddiqui AJ; Khan MF; Hamadou WS; Goyal M; Jahan S; Jamal A; Ashraf SA; Sharma P; Sachidanandan M; Badraoui R; Chaubey KK; Snoussi M; Adnan M
    Medicina (Kaunas); 2021 Oct; 57(10):. PubMed ID: 34684095
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Parthenolide reverses the epithelial to mesenchymal transition process in breast cancer by targeting TGFbeta1: In vitro and in silico studies.
    Sufian HB; Santos JM; Khan ZS; Halim SA; Khan A; Munir MT; Zahid MK; Al-Harrasi A; Gollahon LS; Hussain F; Rahman SM
    Life Sci; 2022 Jul; 301():120610. PubMed ID: 35525305
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Screening of a composite library of clinically used drugs and well-characterized pharmacological compounds for cystathionine β-synthase inhibition identifies benserazide as a drug potentially suitable for repurposing for the experimental therapy of colon cancer.
    Druzhyna N; Szczesny B; Olah G; Módis K; Asimakopoulou A; Pavlidou A; Szoleczky P; Gerö D; Yanagi K; Törö G; López-García I; Myrianthopoulos V; Mikros E; Zatarain JR; Chao C; Papapetropoulos A; Hellmich MR; Szabo C
    Pharmacol Res; 2016 Nov; 113(Pt A):18-37. PubMed ID: 27521834
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Screening of FDA approved drugs for finding potential inhibitors against Granzyme B as a potent drug-repurposing target.
    Ikram S; Ahmad J; Durdagi S
    J Mol Graph Model; 2020 Mar; 95():107462. PubMed ID: 31786094
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hydroxypropyl‑β‑cyclodextrin attenuates the epithelial‑to‑mesenchymal transition via endoplasmic reticulum stress in MDA‑MB‑231 breast cancer cells.
    Wu Y; Zhao Y; He X; He Z; Wang T; Wan L; Chen L; Yan N
    Mol Med Rep; 2020 Jan; 21(1):249-257. PubMed ID: 31746388
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.